Clinical Trials Browser

Recruiting × Prostate Cancer Metastatic × Androgen Antagonists × Clear all

NCT04983095 2026-02-17

METRO

Phase NA Recruiting

Prostate Cancer Metastatic

NCT06320067 2025-09-26

STAMPEDE2

Phase 3 Recruiting

Prostate Cancer Metastatic

NCT04916613 2024-09-26

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

Phase 3 Recruiting

Prostate Cancer Metastatic